Literature DB >> 4027115

Attempts to phenotype human liver samples in vitro for debrisoquine 4-hydroxylase activity.

A R Boobis, C E Hampden, S Murray, P Beaune, D S Davies.   

Abstract

Twenty-eight samples of human liver have been characterised for cytochrome P-450 content, aldrin epoxidase, debrisoquine 4-hydroxylase and bufuralol 1'-hydroxylase activities. Evidence is presented here and elsewhere that bufuralol 1'-hydroxylase and debrisoquine 4-hydroxylase are activities catalysed by the same form of cytochrome P-450 in man, and that this form is different from that catalysing the epoxidation of aldrin. Attempts to phenotype liver samples in vitro, in the absence of any metabolic data in vivo for debrisoquine 4-hydroxylation status, met with limited success. A combination of enzyme assays will most probably be required in any such phenotyping of human liver samples.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027115      PMCID: PMC1463883          DOI: 10.1111/j.1365-2125.1985.tb02706.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  22 in total

1.  Growth hormone and drug metabolism. Acute effects on microsomal mixed-function oxidase activities in rat liver.

Authors:  J T Wilson; T C Spelsberg
Journal:  Biochem J       Date:  1976-02-15       Impact factor: 3.857

2.  Drug metabolism in human liver in vitro: establishment of a human liver bank.

Authors:  C von Bahr; C G Groth; H Jansson; G Lundgren; M Lind; H Glaumann
Journal:  Clin Pharmacol Ther       Date:  1980-06       Impact factor: 6.875

3.  Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver.

Authors:  D S Davies; G C Kahn; S Murray; M J Brodie; A R Boobis
Journal:  Br J Clin Pharmacol       Date:  1981-01       Impact factor: 4.335

4.  Comparative metabolism of benzo[a]pyrene and drugs in human liver.

Authors:  J Kapitulnik; P J Popper; A H Conney
Journal:  Clin Pharmacol Ther       Date:  1977-02       Impact factor: 6.875

5.  Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens.

Authors:  A R Boobis; M J Brodie; G C Kahn; D R Fletcher; J H Saunders; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

6.  Cytochrome P-450 monooxygenase activities in human and rat liver microsomes.

Authors:  P Kremers; P Beaune; T Cresteil; J de Graeve; S Columelli; J P Leroux; J E Gielen
Journal:  Eur J Biochem       Date:  1981-09-01

7.  Aldrin epoxidation, a highly sensitive indicator specific for cytochrome P-450-dependent mono-oxygenase activities.

Authors:  T Wolff; E Deml; H Wanders
Journal:  Drug Metab Dispos       Date:  1979 Sep-Oct       Impact factor: 3.922

8.  Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.

Authors:  O Pelkonen; E Sotaniemi; O Tokola; J T Ahokas
Journal:  Drug Metab Dispos       Date:  1980 Jul-Aug       Impact factor: 3.922

9.  Polymorphic hydroxylation of Debrisoquine in man.

Authors:  A Mahgoub; J R Idle; L G Dring; R Lancaster; R L Smith
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

10.  Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro.

Authors:  M J Brodie; A R Boobis; C J Bulpitt; D S Davies
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more
  4 in total

1.  A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking.

Authors:  D Sesardic; A R Boobis; R J Edwards; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

2.  Tolbutamide 4-hydroxylase activity of human liver microsomes: effect of inhibitors.

Authors:  H S Purba; D J Back; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

3.  The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites.

Authors:  H S Purba; J L Maggs; M L Orme; D J Back; B K Park
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

4.  Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.

Authors:  D Sesardic; A R Boobis; B P Murray; S Murray; J Segura; R de la Torre; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.